Ariel Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Sell
3,014
-215
-7% -$19.7K ﹤0.01% 102
2025
Q4
$290K Sell
3,229
-391,486
-99% -$37.1M ﹤0.01% 104
2025
Q3
$38.9M Buy
394,715
+141,525
+56% +$14M 0.42% 56
2025
Q2
$23.1M Sell
253,190
-46,733
-16% -$4.52M 0.26% 69
2025
Q1
$33.9M Buy
299,923
+1,822
+0.6% +$195K 0.4% 64
2024
Q4
$31.5M Buy
298,101
+847
+0.3% +$90.9K 0.34% 72
2024
Q3
$32.1M Sell
297,254
-147
-0% -$16K 0.33% 70
2024
Q2
$32.3M Buy
297,401
+8,592
+3% +$1.01M 0.35% 72
2024
Q1
$38.1M Sell
288,809
-24,539
-8% -$3.07M 0.37% 73
2023
Q4
$38.1M Sell
313,348
-3,358
-1% -$375K 0.38% 72
2023
Q3
$35.5M Buy
316,706
+21,971
+7% +$2.79M 0.38% 71
2023
Q2
$42.9M Sell
294,735
-62,846
-18% -$8.54M 0.41% 67
2023
Q1
$46.2M Sell
357,581
-925
-0.3% -$116K 0.44% 66
2022
Q4
$45.7M Sell
358,506
-35,846
-9% -$4.16M 0.46% 62
2022
Q3
$41.2M Sell
394,352
-17,540
-4% -$1.92M 0.45% 61
2022
Q2
$43.3M Sell
411,892
-5,808
-1% -$689K 0.43% 64
2022
Q1
$53.4M Buy
417,700
+14,107
+3% +$1.7M 0.47% 60
2021
Q4
$49.8M Buy
403,593
+30,368
+8% +$3.97M 0.42% 64
2021
Q3
$53M Buy
373,225
+12,599
+3% +$1.85M 0.49% 59
2021
Q2
$56.3M Sell
360,626
-70,946
-16% -$11.5M 0.53% 57
2021
Q1
$67.1M Sell
431,572
-11,965
-3% -$1.85M 0.66% 50
2020
Q4
$66.4M Sell
443,537
-46,312
-9% -$6.54M 0.75% 45
2020
Q3
$64.7M Sell
489,849
-4,617
-0.9% -$603K 0.94% 38
2020
Q2
$57.3M Buy
494,466
+4,116
+0.8% +$474K 0.87% 43
2020
Q1
$48.1M Sell
490,350
-49,027
-9% -$6.43M 0.84% 44
2019
Q4
$78.4M Sell
539,377
-3,758
-0.7% -$519K 0.98% 38
2019
Q3
$72.4M Sell
543,135
-184,279
-25% -$23.8M 0.96% 40
2019
Q2
$83.2M Sell
727,414
-4,406
-0.6% -$516K 1.04% 35
2019
Q1
$90.7M Sell
731,820
-93,365
-11% -$10.6M 1.13% 29
2018
Q4
$83.1M Sell
825,185
-106,127
-11% -$11.9M 1.16% 30
2018
Q3
$119M Sell
931,312
-39,536
-4% -$4.7M 1.32% 26
2018
Q2
$105M Sell
970,848
-13,328
-1% -$1.45M 1.18% 29
2018
Q1
$104M Sell
984,176
-51,458
-5% -$5.98M 1.19% 28
2017
Q4
$121M Sell
1,035,634
-53,553
-5% -$6.06M 1.37% 22
2017
Q3
$124M Sell
1,089,187
-4,726
-0.4% -$546K 1.44% 22
2017
Q2
$136M Sell
1,093,913
-15,302
-1% -$1.81M 1.61% 17
2017
Q1
$132M Sell
1,109,215
-54,225
-5% -$6.15M 1.55% 21
2016
Q4
$117M Buy
1,163,440
+128,135
+12% +$13.7M 1.38% 27
2016
Q3
$131M Sell
1,035,305
-222,313
-18% -$27.5M 1.58% 17
2016
Q2
$147M Sell
1,257,618
-55,452
-4% -$6.28M 1.85% 10
2016
Q1
$136M Sell
1,313,070
-62,489
-5% -$6.04M 1.64% 19
2015
Q4
$137M Buy
1,375,559
+72,694
+6% +$7.11M 1.64% 19
2015
Q3
$119M Buy
1,302,865
+173,069
+15% +$17.3M 1.48% 22
2015
Q2
$120M Buy
1,129,796
+37,580
+3% +$4.16M 1.35% 24
2015
Q1
$125M Buy
1,092,216
+20,022
+2% +$2.28M 1.4% 23
2014
Q4
$118M Sell
1,072,194
-6,585
-0.6% -$694K 1.36% 24
2014
Q3
$105M Buy
1,078,779
+303,124
+39% +$29.8M 1.36% 24
2014
Q2
$78.2M Sell
775,655
-205,401
-21% -$20M 0.96% 39
2014
Q1
$90.1M Buy
981,056
+24,433
+3% +$2.25M 1.1% 36
2013
Q4
$86.6M Buy
956,623
+18,680
+2% +$1.62M 1.06% 37
2013
Q3
$74.8M Buy
937,943
+30,605
+3% +$2.41M 1.09% 40
2013
Q2
$66M Buy
+907,338
New +$67.8M 1.08% 39

Other funds holding ZBH

Ariel Investments's ZBH Position: Q1 2026 in Review

Ariel Investments reduced its Zimmer Biomet (ZBH) stake by 6.7% in Q1 2026, selling an estimated $19.7K and leaving 3,014 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #102.

Ariel Investments first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $147M in Q2 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Ariel Investments held 3,014 shares of Zimmer Biomet worth $273K as of Q1 2026.
  • Ariel Investments sold 215 Zimmer Biomet shares in Q1 2026, an estimated $19.7K.
  • Zimmer Biomet made up ﹤0.01% of Ariel Investments's portfolio in Q1 2026, its #102 holding.
  • Ariel Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Ariel Investments's Zimmer Biomet position peaked at $147M in Q2 2016.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Ariel Investments's 13F filing for Q1 2026, filed 14 May 2026.